{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:02:04Z","timestamp":1780484524558,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.leukres.2022.106883","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T20:49:53Z","timestamp":1654030193000},"page":"106883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinical and biological relevance of CREB3L1 in Philadelphia chromosome-negative myeloproliferative neoplasms"],"prefix":"10.1016","volume":"119","author":[{"given":"Federico","family":"De Marchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soji","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terumi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Horino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiho","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marito","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0169-328X(99)00102-3","article-title":"Identification of a novel gene, OASIS, which encodes for a putative CREB\/ATF family transcription factor in the long-term cultured astrocytes and gliotic tissue","volume":"69","author":"Honma","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ncomms1971","article-title":"Unfolded protein response, activated by OASIS family transcription factors, promotes astrocyte differentiation","volume":"3","author":"Saito","year":"2012","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.leukres.2022.106883_bib3","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1471-4159.2005.03596.x","article-title":"Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stress","volume":"96","author":"Murakami","year":"2006","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.leukres.2022.106883_bib4","doi-asserted-by":"crossref","first-page":"C901","DOI":"10.1152\/ajpcell.00292.2014","article-title":"Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 3. Orchestrating the unfolded protein response in oncogenesis: an update","volume":"307","author":"Manie","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"10","key":"10.1016\/j.leukres.2022.106883_bib5","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI0216784","article-title":"Translational control in the endoplasmic reticulum stress response","volume":"110","author":"Ron","year":"2002","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.leukres.2022.106883_bib6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.trecan.2016.03.007","article-title":"Endoplasmic reticulum stress and the hallmarks of cancer","volume":"2","author":"Urra","year":"2016","journal-title":"Trends Cancer"},{"issue":"10","key":"10.1016\/j.leukres.2022.106883_bib7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ncb1963","article-title":"Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation","volume":"11","author":"Murakami","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.chom.2011.06.006","article-title":"The membrane-bound transcription factor CREB3L1 is activated in response to virus infection to inhibit proliferation of virus-infected cells","volume":"10","author":"Denard","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"24","key":"10.1016\/j.leukres.2022.106883_bib9","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1128\/MCB.00959-13","article-title":"CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion, and angiogenesis","volume":"33","author":"Mellor","year":"2013","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.leukres.2022.106883_bib10","article-title":"Sustained Induction of Collagen Synthesis by TGF-\u03b2 Requires Regulated Intramembrane Proteolysis of CREB3L1","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"W1","key":"10.1016\/j.leukres.2022.106883_bib11","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.leukres.2022.106883_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41467-017-01052-y","article-title":"Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1","volume":"8","author":"Feng","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-016-0672-x","article-title":"Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers","volume":"18","author":"Ward","year":"2016","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.leukres.2022.106883_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/cas.14763","article-title":"CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome\u2013negative myeloproliferative neoplasms","volume":"112","author":"Morishita","year":"2021","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.leukres.2022.106883_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.33314\/jnhrc.v17i4.1042","article-title":"The declaration of Helsinki on medical research involving human subjects: a review of seventh revision","volume":"17","author":"Shrestha","year":"2020","journal-title":"J. Nepal Health Res. Counc."},{"issue":"7","key":"10.1016\/j.leukres.2022.106883_bib17","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.1002\/ajh.24752","article-title":"The 2016 WHO diagnostic criteria for polycythemia vera renders an accurate diagnosis to a broader range of patients including masked polycythemia vera: Comparison with the 2008 WHO diagnostic criteria","volume":"92","author":"Misawa","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2022.106883_bib18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/ejh.13041","article-title":"The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort","volume":"100","author":"Ochiai","year":"2018","journal-title":"Eur. J. Haematol."},{"issue":"20","key":"10.1016\/j.leukres.2022.106883_bib19","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2022.106883_bib20","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.3324\/haematol.2014.115113","article-title":"JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms","volume":"100","author":"Shirane","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.leukres.2022.106883_bib21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12185-014-1567-1","article-title":"JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan","volume":"99","author":"Edahiro","year":"2014","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2022.106883_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-59745-257-1_25","article-title":"Quantitative polymerase chain reaction","volume":"362","author":"Peirson","year":"2007","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.leukres.2022.106883_bib23","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/blood-2015-09-671172","article-title":"Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms","volume":"127","author":"Araki","year":"2016","journal-title":"Blood"},{"issue":"4551","key":"10.1016\/j.leukres.2022.106883_bib24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.6177045","article-title":"HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression","volume":"216","author":"Martin","year":"1982","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.leukres.2022.106883_bib25","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood.V87.11.4552.bloodjournal87114552","article-title":"Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7\/TPO","volume":"87","author":"Komatsu","year":"1996","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2022.106883_bib26","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1074\/jbc.M116.745398","article-title":"Histone acetyltransferase p300\/CREB-binding protein-associated Factor (PCAF) is required for all-trans-retinoic acid-induced granulocytic differentiation in leukemia cells","volume":"292","author":"Sunami","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41375-018-0181-2","article-title":"Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation","volume":"33","author":"Araki","year":"2019","journal-title":"Leukemia"},{"issue":"40","key":"10.1016\/j.leukres.2022.106883_bib28","doi-asserted-by":"crossref","first-page":"68191","DOI":"10.18632\/oncotarget.19277","article-title":"Tunicamycin induced endoplasmic reticulum stress promotes apoptosis of prostate cancer cells by activating mTORC1","volume":"8","author":"Guha","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014591","article-title":"Proteasome inhibition represses unfolded protein response and Nox4, sensitizing vascular cells to endoplasmic reticulum stress-induced death","volume":"6","author":"Amanso","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.leukres.2022.106883_bib30","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.bbamcr.2016.05.002","article-title":"Unfolded protein response induced by Brefeldin A increases collagen type I levels in hepatic stellate cells through an IRE1\u03b1, p38 MAPK and Smad-dependent pathway","volume":"1863","author":"De Galarreta","year":"2016","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Res."},{"issue":"2","key":"10.1016\/j.leukres.2022.106883_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nmeth.2811","article-title":"BoxPlotR: a web tool for generation of box plots","volume":"11","author":"Spitzer","year":"2014","journal-title":"Nat. Methods"},{"issue":"10","key":"10.1016\/j.leukres.2022.106883_bib32","first-page":"2258","article-title":"[Statistical analysis using freely-available \"EZR (Easy R)\" software]","volume":"56","author":"Kanda","year":"2015","journal-title":"Rinsho Ketsueki"},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib33","article-title":"Essential thrombocythemia treatment algorithm 2018, Blood","volume":"8","author":"Tefferi","year":"2018","journal-title":"Cancer J."},{"issue":"4","key":"10.1016\/j.leukres.2022.106883_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hon.2670","article-title":"Comparison between thrombotic risk scores in essential thrombocythemia and survival implications","volume":"37","author":"Santoro","year":"2019","journal-title":"Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2022.106883_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-020-0289-2","article-title":"Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis","volume":"10","author":"Guglielmelli","year":"2020","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.leukres.2022.106883_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ajh.24293","article-title":"Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 Mayo clinic patients","volume":"91","author":"Haider","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.leukres.2022.106883_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.95","article-title":"Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors","volume":"5","author":"Cerquozzi","year":"2015","journal-title":"Blood Cancer J."},{"issue":"2","key":"10.1016\/j.leukres.2022.106883_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054060","article-title":"OASIS\/CREB3L1 is induced by endoplasmic reticulum stress in human glioma cell lines and contributes to the unfolded protein response, extracellular matrix production and cell migration","volume":"8","author":"Vellanki","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.leukres.2022.106883_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0006-291X(02)00253-X","article-title":"OASIS is a transcriptional activator of CREB\/ATF family with a transmembrane domain","volume":"293","author":"Omori","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.leu.2401608","article-title":"Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles","volume":"14","author":"Uozumi","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2022.106883_bib43","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.phrs.2017.04.003","article-title":"Targeting the unfolded protein response in cancer","volume":"120","author":"Ojha","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.leukres.2022.106883_bib44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.201304054","article-title":"The incredible journey: from megakaryocyte development to platelet formation","volume":"201","author":"Machlus","year":"2013","journal-title":"J. Cell Biol."},{"issue":"11","key":"10.1016\/j.leukres.2022.106883_bib45","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3390\/cells10112965","article-title":"The unfolded protein response as a guardian of the secretory pathway","volume":"10","author":"Radanovi\u0107","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.leukres.2022.106883_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.leukres.2022.106883_bib47","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.leukres.2022.106883_bib48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bjh.16152","article-title":"Platelets in myeloproliferative neoplasms have a distinct transcript signature in the presence of marrow fibrosis","volume":"188","author":"Guo","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"13","key":"10.1016\/j.leukres.2022.106883_bib49","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1182\/blood-2011-03-344408","article-title":"Blood platelets contain tumor-derived RNA biomarkers","volume":"118","author":"Nilsson","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2022.106883_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133070","article-title":"Differential expression analysis by RNA-Seq reveals perturbations in the platelet mRNA transcriptome triggered by pathogen reduction systems","volume":"10","author":"Osman","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.leukres.2022.106883_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/CBI20110383","article-title":"Fibronectin promotes proplatelet formation in the human megakaryocytic cell line UT-7\/TPO","volume":"36","author":"Kawaguchi","year":"2012","journal-title":"Cell Biol. Int."},{"issue":"12","key":"10.1016\/j.leukres.2022.106883_bib52","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk\u2010stratification and management","volume":"95","author":"Tefferi","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2022.106883_bib53","article-title":"Analysis of cell viability by the lactate dehydrogenase assay","volume":"2018","author":"Kumar","year":"2018","journal-title":"Cold Spring Harbor Protoc."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622001096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622001096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:02:25Z","timestamp":1758934945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622001096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":53,"alternative-id":["S0145212622001096"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106883","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and biological relevance of CREB3L1 in Philadelphia chromosome-negative myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106883"}}